Eko Devices Inc. has raised $20 million in new venture capital after selling investors and health-care providers on the promise of using machine learning to combat heart disease.
Eko combines machine learning with software and devices designed to help physicians identify heart conditions more quickly.
Read more at The Wall Street Journal